These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 62430)

  • 21. Graft versus leukemia without fatal graft-versus-host disease in AKR mice.
    Chester SJ; Esparza AR; Albala MM
    Cancer Res; 1975 Mar; 35(3):637-9. PubMed ID: 234789
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The graft-versus-host reaction and immune function. III. Functional pre-T cells in the bone marrow of graft-versus-host-reactive mice displaying T cell immunodeficiency.
    Seddik M; Seemayer TA; Lapp WS
    Transplantation; 1986 Feb; 41(2):238-42. PubMed ID: 3484849
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Non-H-2 foreign alloantigens on chemically induced sarcoma cells as detected by graft-versus-host reaction [proceedings].
    Parmiani G; Invernizzi G
    Folia Biol (Praha); 1976; 22(6):395-6. PubMed ID: 12029
    [No Abstract]   [Full Text] [Related]  

  • 24. Retention of graft-vs-host activity in non-adherent spleen cells after depletion of cytotoxic activity by incubation on allogeneic target cells.
    Mage MG; McHugh LL
    J Immunol; 1973 Aug; 111(2):652-5. PubMed ID: 4146231
    [No Abstract]   [Full Text] [Related]  

  • 25. Suppression of graft versus host reactivity by a single host-specific blood transfusion to prospective donors of hemopoietic cells.
    Knulst AC; Bril-Bazuin C; Ruizeveld de Winter JA; Benner R
    Transplant Proc; 1990 Aug; 22(4):1975-6. PubMed ID: 2389502
    [No Abstract]   [Full Text] [Related]  

  • 26. Suppression of the mixed leukocyte response and of graft-vs-host disease by spleen cells following total lymphoid irradiation (TLI).
    King DP; Srober S; Kaplan HS
    J Immunol; 1981 Mar; 126(3):1140-5. PubMed ID: 6450802
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mutual recognition of parental and F1 lymphocytes. II. Analysis of graft-vs-host-induced suppressor cell activity for T cell-mediated lympholysis to trinitrophenyl self and alloantigens.
    Polisson RP; Shearer GM
    J Immunol; 1980 Oct; 125(4):1865-61. PubMed ID: 6967920
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inappropriate alloantigen-like specificities detected on reticulum cell sarcomas of SJL/J mice: characterization and biologic role.
    Bonavida B; Roman JM; Hutchinson IV
    Transplant Proc; 1980 Mar; 12(1):59-64. PubMed ID: 6154360
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Specific depletion of graft-versus-host activity of normal or allosensitized parental spleen cells.
    Rózalska B
    Arch Immunol Ther Exp (Warsz); 1983; 31(4):417-21. PubMed ID: 6200087
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Graft-vs-host reactivity of mouse thymocytes: effect of cortisone pretreatment of donors.
    Tigelaar RE; Asofsky R
    J Immunol; 1973 Feb; 110(2):567-74. PubMed ID: 4405321
    [No Abstract]   [Full Text] [Related]  

  • 31. Immunosuppression of normal lymphoid cells by serum from mice undergoing chronic graft-vs-host disease.
    McMaster R; Levy JG
    J Immunol; 1975 Nov; 115(5):1400-3. PubMed ID: 240891
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The influence of graft-versus-host reactivity, lymphocyte depletion, and cell dose on allogeneic bone marrow engraftment.
    Glass B; Uharek L; Gaska T; Gassmann W; Löffler H; Müller-Ruchholtz W
    Bone Marrow Transplant; 1993; 12 Suppl 3():S41-7. PubMed ID: 8124257
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Unexpected role of TNF-alpha in graft versus host reaction (GVHR): donor-derived TNF-alpha suppresses GVHR via inhibition of IFN-gamma-dependent donor type-1 immunity.
    Yamamoto S; Tsuji T; Matsuzaki J; Zhange Y; Chamoto K; Kosaka A; Togashi Y; Sekikawa K; Sawada K; Takeshima T; Koike T; Nishimura T
    Int Immunol; 2004 Jun; 16(6):811-7. PubMed ID: 15126416
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumor induction by immunologically activated murine leukemia virus: cellular immunity early in the graft-vs-host reaction.
    Ruddle NH; Armstrong MY; Richards FF
    J Immunol; 1974 Feb; 112(2):706-15. PubMed ID: 4149884
    [No Abstract]   [Full Text] [Related]  

  • 35. Age-related changes in cell-mediated immunity in BALB/C mice.
    Walters CS; Claman HN
    J Immunol; 1975 Nov; 115(5):1438-43. PubMed ID: 240893
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of monosodium glutamate on cell-mediated immunity.
    Kubera M; Bubak-Satora M; Skowron-Cendrzak A; Mazur-Kolecka B; Stĕdra J; Holán V
    Pol J Pharmacol Pharm; 1991; 43(1):39-44. PubMed ID: 1771162
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-recipient cytotoxic T lymphocyte precursors are present in the spleens of mice with acute graft versus host disease due to minor histocompatibility antigens.
    Hamilton BL; Bevan MJ; Parkman R
    J Immunol; 1981 Feb; 126(2):621-5. PubMed ID: 6450246
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The target minor H antigen for F1 cytotoxic T lymphocytes induced by Igh-congenic parental spleen cells is coded for by gene linked to H-2.
    Ishikawa H; Kubota E; Suzuki H; Saito K
    J Immunol; 1985 May; 134(5):2953-9. PubMed ID: 2580009
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Augmentation of cellular immunity by kigamicin D.
    Masuda T; Ohba S; Kawada M; Iijima M; Inoue H; Osono M; Ikeda D; Kunimoto S
    J Antibiot (Tokyo); 2006 Apr; 59(4):215-9. PubMed ID: 16830888
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Suppressors of the graft vs graft reaction in tolerance to alloantigens].
    Cherniakhovskaia IIu; Prigozhina TB; Nagurskaia EV; Fontalin LN
    Biull Eksp Biol Med; 1988 Jun; 105(6):697-700. PubMed ID: 2968819
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.